Cannabis bliss?: Perhaps not?

Neurology

Volumn 71, Issue 3, 2008, Pages 160-161

  Arnett, Peter A ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; PLANT EXTRACT;

ANXIETY; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CANNABIS SMOKING; CLINICAL PRACTICE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; EDITORIAL; HEARING ACUITY; HUMAN; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRY; QUALITY OF LIFE; SAMPLE SIZE; SCIENTIFIC LITERATURE; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; CHEMICALLY INDUCED DISORDER; NOTE; PSYCHOLOGICAL ASPECT;

CANNABIS; HUMANS; MARIJUANA SMOKING; MENTAL DISORDERS; MULTIPLE SCLEROSIS; PLANT EXTRACTS;

EID: 48449094496     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000317096.16068.82     Document Type: Editorial

References (8)

1. Freeman RM, Odekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMSLUTS). Int J Pelvic Floor Dysfunction 2006;17:636-641.
2. Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-819.
3. Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. Neurology 2004;62:2098-2100.
4. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003;30:201-205.
5. Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003;362:1517-1526.
6. Ghaffar O, Feinstein A. Multiple sclerosis and cannabis: a cognitive and psychiatric study. Neurology 2008;71:164-169.
7. Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology 1996;46:628-632.
8. Croxford JL, Pryce G, Jackson SJ, et al. Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. J Neuroimmunol 2008;193:120-129.